PsychoactiveMap

Disclaimer

Important information about this platform

Last updated: February 11, 2026

Critical Notice - Please Read

This platform is for educational and research purposes ONLY. Do not use this information for medical decisions, legal advice, or as a substitute for professional consultation. Psychedelic substances are controlled in most jurisdictions and can have serious health risks.

1. Medical Disclaimer

NOT MEDICAL ADVICE

The information on PsychoactiveMap is NOT intended to:

  • Diagnose, treat, cure, or prevent any disease or medical condition
  • Provide medical advice or recommendations
  • Replace consultation with qualified healthcare professionals
  • Serve as a substitute for professional medical judgment

Always consult with qualified healthcare professionals before:

  • Making any medical decisions
  • Starting, stopping, or changing any medication or treatment
  • Participating in clinical trials or research studies
  • Using any psychedelic or other substances

Emergency Disclaimer

If you are experiencing a medical emergency, call emergency services immediately (911 in the US). Do NOT rely on information from this Platform in emergency situations.

No Doctor-Patient Relationship: Use of this Platform does not create a doctor-patient or any other healthcare provider-patient relationship between you and PsychoactiveMap.

2. Not a HIPAA Covered Entity

HIPAA Status

PsychoactiveMap is an educational platform, not a healthcare provider, health plan, or healthcare clearinghouse. We are NOT a HIPAA-covered entity.

Do NOT share Protected Health Information (PHI):

  • Do not submit medical records, diagnoses, or treatment information
  • Do not share personal health information through contact forms
  • We do not collect or process Protected Health Information
  • We are not subject to HIPAA privacy and security requirements

If you need to discuss personal health matters, consult directly with licensed healthcare providers in secure, HIPAA-compliant environments.

4. Clinical Trial Information

Clinical trial data displayed on PsychoactiveMap is compiled from publicly available sources, primarily ClinicalTrials.gov and other research databases.

Important Limitations:

  • Data may be outdated: Trial status, enrollment, and details change frequently
  • Not enrollment assistance: We do not facilitate trial enrollment or screen participants
  • Contact institutions directly: For current information and enrollment, contact research institutions directly
  • Strict criteria apply: Clinical trials have inclusion/exclusion criteria that may disqualify many applicants
  • No guarantees: Participation in trials does not guarantee access to treatment or positive outcomes

We are not responsible for:

  • Trial outcomes, adverse events, or participant experiences
  • Accuracy of trial information (verify with institutions)
  • Enrollment decisions or participant selection
  • Research ethics or institutional practices

5. Research Information Accuracy

While we strive to provide accurate information, we cannot guarantee the completeness, accuracy, or timeliness of research data displayed on the Platform.

Data Sources

Information is compiled from ClinicalTrials.gov, PubMed, government databases, and other public sources. Original sources may contain errors or be outdated.

Update Frequency

Data is updated periodically (not in real-time). Manual and automated updates may have delays. Always verify critical information with original sources.

Geocoding Limitations

Geographic locations are determined through automated geocoding and may contain errors. Institution locations may be approximate or incorrect.

False Positives Possible

Our "banned studies" feature allows flagging studies that may not be genuine psychedelic research (e.g., oncology studies using compound names coincidentally). Some false positives may remain.

User Reporting Encouraged: If you find inaccurate information, please report it so we can investigate and correct it.

6. No Endorsement

Inclusion of research, institutions, researchers, companies, or other entities on PsychoactiveMap does NOT constitute:

  • Endorsement of their methods, findings, or practices
  • Verification of their credentials or legitimacy
  • Recommendation to participate in their research or use their services
  • Confirmation of their regulatory compliance or ethical standards
  • Investment advice or financial recommendations

Users should independently evaluate all information, research quality, institutional credibility, and researcher qualifications before making any decisions.

7. No Professional Relationship

Use of this Platform does NOT create any professional relationship, including:

  • Doctor-Patient Relationship: We do not provide medical services or advice
  • Attorney-Client Relationship: We do not provide legal services or advice
  • Researcher-Participant Relationship: We do not conduct research or recruit participants
  • Financial Advisor-Client Relationship: We do not provide investment or financial advice

For professional services, consult licensed professionals in the relevant field.

9. Geographic Limitations

PsychoactiveMap is operated from the United States and intended for a global audience. However:

  • Content may not comply with laws in all jurisdictions
  • Access may be restricted or prohibited in some countries
  • Information may be U.S.-centric and not applicable elsewhere
  • Users are responsible for determining if use is legal in their location

If you access the Platform from outside the United States, you do so at your own risk and are responsible for compliance with local laws.

10. Investment & Financial Disclaimer

Information about companies, research institutions, or financial aspects of psychedelic research is for educational purposes only and does NOT constitute:

  • Investment advice or recommendations
  • Financial planning or guidance
  • Securities analysis or stock recommendations
  • Endorsement of any company or investment opportunity

Do not base investment or financial decisions on Platform information. Consult licensed financial advisors and conduct thorough due diligence before making any investment decisions.

11. Safety Warning

Critical Safety Information

Psychedelic substances can have serious physical and psychological effects, including:

  • Acute psychological distress, anxiety, paranoia, or panic
  • Risk of triggering latent mental health conditions
  • Cardiovascular effects (increased heart rate, blood pressure)
  • Unpredictable reactions and duration of effects
  • Potential for dangerous behavior or self-harm
  • Drug interactions with medications or other substances
  • Long-term psychological effects (flashbacks, HPPD)

Controlled Settings Only

Psychedelic substances should ONLY be used:

  • In controlled, supervised settings
  • As part of legitimate research or therapeutic programs
  • Where legally permitted
  • Under professional medical supervision
  • After thorough medical screening and risk assessment

Do NOT Self-Administer

Self-administration of psychedelic substances is extremely dangerous, likely illegal, and strongly discouraged. This Platform does not support, encourage, or provide guidance for illegal drug use.

12. Contact

For questions about this disclaimer or to report inaccurate information, please contact us.

Acknowledgment: By using PsychoactiveMap, you acknowledge that you have read, understood, and agree to all disclaimers stated on this page.

Related: Terms of Service, Privacy Policy